Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Cardiovascular and Interventional Radiology|March 5, 2003
Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patencyJean-Francois H Geschwind, Douglas E Ramsey, Berry Cleffken, et al.Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicitiesJames E Goin, Riad Salem, Brian I Carr, et al.Anticancer Research|April 16, 2010
3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell linesShanmugasundaram Ganapathy-Kanniappan, Jean-Francois H Geschwind, Rani Kunjithapatham, et al.Radiology|February 4, 2009
Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imagingIhab R Kamel, Eleni Liapi, Diane K Reyes, et al.Korean Journal of Radiology|May 13, 2010
Transcatheter arterial embolization in patients with kidney diseases: an overview of the technical aspects and clinical indicationsRomaric Loffroy, Pramod Rao, Byung-Kook Kwak, et al.Frontiers in Bioengineering and Biotechnology|December 11, 2020
Evaluation of Hydrogen Peroxide Fumigation and Heat Treatment for Standard Emergency Arthropod Inactivation in BSL-3 InsectariesIrina Häcker, Roland Koller, Gerrit Eichner, et al.Gastroenterology|October 28, 2004
Yttrium-90 microspheres for the treatment of hepatocellular carcinomaJean Francois H Geschwind, Riad Salem, Brian I Carr, et al.Cardiovascular and Interventional Radiology|December 31, 2010
Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant listConstantine Frangakis, Jean-Francois Geschwind, Daniel Kim, et al.Cancer|November 8, 2012
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaManon Buijs, Diane K Reyes, Timothy M Pawlik, et al.Liver Cancer|March 19, 2016
Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON RegistryJean-Francois H Geschwind, Pierre M Gholam, Alec Goldenberg, et al.Pageof 13